muscle strain
Conditions
Interventions
For patients diagnosed as Okuwaki classification type II by MRI, Platelet-rich plasma is infiltrated to the muscle injured area under ultrasound guided within 7 days after injury
Sponsors
Department of Orthopaedics Surgery, Faculty of Medicine, University of Tsukuba
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.acute muscle strain 2.Patients diagnosed with Okuwaki classification type II by taking for MRI 3.Be able to treat under ultrasound guidance at our hospital within 1 week after injury 4.Be observable throughout the entire research period
Exclusion criteria
Exclusion criteria: a history of infectious disease and systemic disorders such as diabetes, rheumatoid arthritis, hematological diseases (coagulopathy), severe cardiovascular diseases, infections, or immunodepression; therapy with anticoagulants or an anti-aggregating agent; use of non-steroidal anti-inflammatory drugs 2 weeks before blood sampling; and hemoglobin levels <10 g/dL.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events occurring during platelet-rich plasma use and observation period and its details | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical outcome after using platelet-rich plasma, time course change with MRI | — |
Countries
Japan
Contacts
Public ContactTmokazu Yoshioka
University of tsukuba Division of Regenerative Medicine for Musculoskeletal System
Outcome results
None listed